Fischer Medical [FISCHER] vs Nureca [NURECA] Detailed Stock Comparison
Fischer Medical
BSE
Loading...
Nureca
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Fischer Medical wins in 7 metrics, Nureca wins in 10 metrics, with 0 ties. Nureca appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Fischer Medical | Nureca | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 5,062.11 | 306.06 | Nureca |
| Price-to-Book Ratio | 31.78 | 1.22 | Nureca |
| Debt-to-Equity Ratio | 25.27 | 2.56 | Nureca |
| PEG Ratio | N/A | -2.08 | N/A |
| EV/EBITDA | 2,754.24 | -16.87 | Nureca |
| Profit Margin (TTM) | 1.31% | 0.00% | Fischer Medical |
| Operating Margin (TTM) | 4.05% | -3.20% | Fischer Medical |
| EBITDA Margin (TTM) | 4.05% | N/A | N/A |
| Return on Equity | 0.57% | 0.44% | Fischer Medical |
| Return on Assets (TTM) | 0.73% | 0.40% | Fischer Medical |
| Free Cash Flow (TTM) | $-922.39M | $-234.06M | Nureca |
| 1-Year Return | 50.52% | -11.54% | Fischer Medical |
| Price-to-Sales Ratio (TTM) | 56.37 | 1.92 | Nureca |
| Enterprise Value | $105.60B | $1.19B | Fischer Medical |
| EV/Revenue Ratio | 94.12 | 0.96 | Nureca |
| Gross Profit Margin (TTM) | 20.06% | 35.11% | Nureca |
| Revenue per Share (TTM) | $17 | $123 | Nureca |
| Earnings per Share (Diluted) | $0.19 | $0.85 | Nureca |
| Beta (Stock Volatility) | -0.02 | 0.49 | Fischer Medical |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Fischer Medical vs Nureca Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Fischer Medical | -1.36% | 0.59% | 21.01% | 27.48% | 35.46% | 36.48% |
| Nureca | 0.50% | -1.64% | -16.97% | -0.30% | -15.73% | -16.64% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Fischer Medical | 50.52% | 2,061.35% | 2,131.55% | 1,379.69% | 10,586.67% | 10,879.45% |
| Nureca | -11.54% | -77.12% | -65.05% | -65.05% | -65.05% | -65.05% |
Performance & Financial Health Analysis: Fischer Medical vs Nureca
| Metric | FISCHER | NURECA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹63.24B | ₹2.37B |
| Market Cap Category | Mid cap | Small cap |
| 10 Day Avg. Volume | 3,303 | 12,784 |
| 90 Day Avg. Volume | 13,029 | 18,933 |
| Last Close | ₹961.80 | ₹236.98 |
| 52 Week Range | ₹573.60 - ₹1,000.00 | ₹203.62 - ₹447.50 |
| % from 52W High | -3.82% | -47.04% |
| All-Time High | ₹2,386.00 (Apr 21, 2008) | ₹2,315.00 (Oct 04, 2021) |
| % from All-Time High | -59.69% | -89.76% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 1.37% | 0.69% |
| Quarterly Earnings Growth | -0.35% | -0.51% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.00% |
| Operating Margin (TTM) | 0.04% | -0.03% |
| Return on Equity (TTM) | 0.01% | 0.00% |
| Debt to Equity (MRQ) | 25.27 | 2.56 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹30.27 | ₹194.28 |
| Cash per Share (MRQ) | ₹22.54 | ₹123.05 |
| Operating Cash Flow (TTM) | ₹-862,518,016 | ₹-172,050,000 |
| Levered Free Cash Flow (TTM) | ₹-547,108,480 | ₹8.46M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Fischer Medical vs Nureca
| Metric | FISCHER | NURECA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 5,062.11 | 306.06 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | -2.08 |
| Price to Sales (TTM) | 56.37 | 1.92 |
| Price to Book (MRQ) | 31.78 | 1.22 |
| Market Capitalization | ||
| Market Capitalization | ₹63.24B | ₹2.37B |
| Enterprise Value | ₹105.60B | ₹1.19B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 94.12 | 0.96 |
| Enterprise to EBITDA | 2,754.24 | -16.87 |
| Risk & Other Metrics | ||
| Beta | -0.02 | 0.49 |
| Book Value per Share (MRQ) | ₹30.27 | ₹194.28 |
Financial Statements Comparison: Fischer Medical vs Nureca
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | FISCHER | NURECA |
|---|---|---|
| Revenue/Sales | ₹491.74M | ₹341.76M |
| Cost of Goods Sold | ₹393.11M | ₹221.78M |
| Gross Profit | ₹98.64M | ₹119.98M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹19.93M | ₹-10.93M |
| EBITDA | ₹25.49M | ₹20.11M |
| Pre-Tax Income | ₹18.12M | ₹12.31M |
| Income Tax | ₹5.00M | ₹4.18M |
| Net Income (Profit) | ₹13.12M | ₹8.13M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | FISCHER | NURECA |
|---|---|---|
| Cash & Equivalents | ₹1.04B | ₹32.41M |
| Total Current Assets | ₹3.65B | ₹1.90B |
| Total Current Liabilities | ₹815.68M | ₹123.99M |
| Long-Term Debt | ₹374.59M | ₹25.90M |
| Total Shareholders Equity | ₹3.38B | ₹1.94B |
| Retained Earnings | N/A | ₹868.20M |
| Property, Plant & Equipment | ₹186.04M | ₹70.13M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | FISCHER | NURECA |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | FISCHER | NURECA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 3,303 | 12,784 |
| Average Daily Volume (90 Day) | 13,029 | 18,933 |
| Shares Outstanding | 63.80M | 10.00M |
| Float Shares | 25.71M | 3.39M |
| % Held by Insiders | 0.79% | 0.66% |
| % Held by Institutions | 0.03% | 0.00% |
Dividend Analysis & Yield Comparison: Fischer Medical vs Nureca
| Metric | FISCHER | NURECA |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | ₹0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | ₹0.00 |
| Ex-Dividend Date | N/A | N/A |